PharmaResources (Shanghai) Co. Ltd. A (301230) — Cash Flow-to-Debt Ratio
PharmaResources (Shanghai) Co. Ltd. A (301230) has a Cash Flow-to-Debt Ratio of 0.44x as of December 2025, meaning its operating cash flow of CN¥135.51 Million could theoretically repay 0% of its total liabilities (CN¥309.87 Million) in one year. See PharmaResources (Shanghai) Co. Ltd. A (301230) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
PharmaResources (Shanghai) Co. Ltd. A Cash Flow-to-Debt Ratio (2020–2025)
Historical debt coverage capacity for PharmaResources (Shanghai) Co. Ltd. A across 6 annual periods. For the full cash flow conversion analysis, see 301230 cash flow metrics.
Annual Cash Flow-to-Debt Ratio for PharmaResources (Shanghai) Co. Ltd. A (2020–2025)
Year-by-year debt coverage analysis for PharmaResources (Shanghai) Co. Ltd. A. Check PharmaResources (Shanghai) Co. Ltd. A cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.44x | CN¥135.51 Million | CN¥309.87 Million | ▲ +53.4% |
| 2024 | 0.29x | CN¥80.86 Million | CN¥283.73 Million | ▲ +405.0% |
| 2023 | 0.06x | CN¥20.86 Million | CN¥369.62 Million | ▼ -89.3% |
| 2022 | 0.53x | CN¥99.29 Million | CN¥188.38 Million | ▲ +5.0% |
| 2021 | 0.50x | CN¥105.12 Million | CN¥209.37 Million | ▲ +2.2% |
| 2020 | 0.49x | CN¥54.45 Million | CN¥110.81 Million | — |